跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Viglucon - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Viglucon
Approved
STANDARD
Viglucon
Novartis Pharmaceutica SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ec8da9e59e3ed1b6
Company
Novartis Pharmaceutica SA
Type
Standard
Approval Details
Approval Id
ec8da9e59e3ed1b6
Drug Approval Philippines Name
Viglucon
Product Name
Viglucon
Registration Number
DRP-4796-03
Brand Name
Viglucon
Generic Name
Vildagliptin
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
Novartis Pharmaceutica SA
Importer
Novartis Healthcare Philippines, Inc.
Distributor
Sandoz Philippines Corporation
Issuance Date
29 December 2020
Expiry Date
17 December 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ec8da9e59e3ed1b6
Type
Standard
Back to Philippines FDA Approvals